Haoyue Capital

Haoyue Capital, established in 2014, is committed to creating a network that connects China's healthcare and capital markets. The firm's research and transactions cover a broad range of sectors across biopharma, medical devices, healthcare services and digital health, and IVD and precision medicine. The firm is China's largest team of senior investment bankers devoted exclusively to healthcare and closely tracks the market trends in the healthcare sector. The firm publishes weekly healthcare industry news along with its own perspectives and strives to provide the most up-to-date industry research reports.